Doctor profile · Federal record
Dr. DONALD AMMERMAN, M.D.
Psychiatry Physician (CMS: PSYCHIATRY) · Psychiatry Physician · DANBURY, CT
- NPI 1316032295
- Accepts Medicare
- 21 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
84 HOSPITAL AVE, CPC ASSOCIATES
DANBURY, CT 06810
(203) 792-6060
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- August 20, 2009
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 2084P0800X — NUCC code
- State licenses (2)
- Connecticut #047925 · New Hampshire #RT1438
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316032295. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
536
Distinct HCPCS
2
Medicare allowed
$39,437
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 289 | 54 | $79 | |
90833 |
Psychotherapy with evaluation and management visit, 30 minutes | 247 | 44 | $67 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 146. This provider delivers 3.7× the peer median.Open Payments
Industry payments received
All-time total
$279,657
Transactions
389
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 207 | $135,156.38 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 123 | $111,736.50 | |
| Neurocrine Biosciences, Inc. | 38 | $32,189.22 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $173.43 | |
| Supernus Pharmaceuticals, Inc. | 2 | $86.72 | |
| Teva Pharmaceuticals USA, Inc. | 3 | $74.25 | |
| Janssen Pharmaceuticals, Inc | 3 | $65.04 | |
| Otsuka America Pharmaceutical, Inc. | 3 | $65.03 | |
| Tempus AI, Inc | 2 | $39.60 | |
| Alkermes, Inc. | 2 | $34.64 | |
| Vanda Pharmaceuticals Inc. | 1 | $19.99 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
624
Patients
67
Total drug cost
$67,986
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluoxetine Hcl | Generic | 67 | 0 | $1,860 |
| Quetiapine Fumarate | Generic | 61 | 15 | $1,428 |
| Bupropion Xl (Bupropion Hcl) | Brand | 57 | 17 | $3,123 |
| Trazodone Hcl | Generic | 57 | 11 | $1,648 |
| Duloxetine Hcl | Generic | 50 | 11 | $1,761 |
| Desvenlafaxine Succinate Er (Desvenlafaxine Succinate) | Brand | 43 | 0 | $3,668 |
| Escitalopram Oxalate | Generic | 43 | 13 | $750 |
| Buspirone Hcl | Generic | 38 | 0 | $1,084 |
| Sertraline Hcl | Generic | 38 | 0 | $553 |
| Mirtazapine | Generic | 34 | 0 | $865 |